Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentrica Regulatory News (CNA)

Share Price Information for Centrica (CNA)

Share Price is delayed by 15 minutes
Get Live Data
185.80    0.70 (0.38%)
Bid:
185.70
Ask:
185.85
Spread: 0.15 (0.081%)
Market Cap: £8.41b
CNA Live PriceLast checked at - London Stock Exchange

Intraday Centrica Share Chart

Transaction in Own Shares

3 Apr 2025 07:00

RNS Number : 4229D
Centrica PLC
03 April 2025
Β 

Transactions in own shares

Β 

Centrica plc

3 April 2025

Β 

Centrica plc announces that it purchased on 2 April 2025 (through Merrill Lynch International) 65,811 Centrica plc ordinary shares of 6 14/81 pence each at a price of 150.64 pence per share. The purchased shares will be held as treasury shares. Such purchase was effected pursuant to the extension of the Company's 2024-25 buyback programme announced on 27 December 2024 and in accordance with the non-discretionary share repurchase agreement entered into with Merrill Lynch International as also announced on 27 December 2024, which agreement was subsequently amended as announced on 3 March 2025.

Β 

Since 3 March 2025, Centrica has purchased 30,899,620 ordinary shares at a cost (excluding dealing and associated costs) of Β£45,413,463.76.

Β 

Following the above purchase, Centrica plc holds 453,691,510 ordinary shares in treasury, and has 5,039,415,704 ordinary shares in issue (excluding treasury shares).

Β 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019), detailed information about the individual purchases made by Merrill Lynch International is set out below.

Β 

Transaction details: Centrica plc ordinary shares of 6 14/81 pence each

Β 

Issuer name:

Centrica plc

ISIN:

GB00B033F229

Intermediary name:

Merrill Lynch International

Intermediary Code:

MLILGB3LESF

Currency:

GBP

Β 

Aggregated information

Date of purchase:

2 April 2025

Number of ordinary shares purchased:

65,811

Highest price paid:

152.00p

Lowest price paid:

150.05p

Volume weighted average price paid per share:

150.64p

Β 

Disaggregated information

Β 

The table attached contains detailed information of the individual trades made by Merrill Lynch International, as part of the buyback programme.

Β 

Click on, or paste the following link into your web browser, to view the associated PDF document.

http://www.rns-pdf.londonstockexchange.com/rns/4229D_1-2025-4-2.pdfΒ 

END

Β 

Enquiries:

Investors and Analysts

E: ir@centrica.com

Β 

Β 

Centrica plc is listed on the London Stock Exchange (CNA)

Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654

Legal Entity Identifier number: E26EDV109X6EEPBKVH76

ISIN number: GB00B033F229

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
POSFZGGDVZGGKZM
Date   Source Headline
1st Jun 20263:45 pmRNSTotal Voting Rights
26th May 202612:30 pmRNSDirector/PDMR Shareholding
22nd May 20262:00 pmRNSDirector/PDMR Shareholding
18th May 20264:00 pmRNSDirector/PDMR Shareholding
15th May 20267:00 amRNSBritish Gas agrees PPM settlement
14th May 20264:42 pmRNSPublication of a Prospectus
12th May 20263:15 pmRNSDirector/PDMR Shareholding
12th May 202612:15 pmRNSDirector/PDMR Shareholding
12th May 20267:10 amRNSDirectorate change
7th May 202612:15 pmRNSResult of AGM
7th May 20267:00 amRNSAcquisition of the Severn CCGT for c.£370 million
7th May 20267:00 amRNSAGM Statement
1st May 20262:30 pmRNSTotal Voting Rights
27th Apr 20262:30 pmRNSDirector/PDMR Shareholding
13th Apr 20263:30 pmRNSDirector/PDMR Shareholding
1st Apr 202612:00 pmRNSTotal Voting Rights
31st Mar 202610:33 amRNSNotice of AGM
25th Mar 20262:00 pmRNSDirector/PDMR Shareholding
11th Mar 20266:15 pmRNSDirector/PDMR Shareholding
2nd Mar 202612:15 pmRNSTotal Voting Rights
25th Feb 20265:15 pmRNSDirector/PDMR Shareholding
19th Feb 20262:39 pmRNSAnnual Financial Report 2025
19th Feb 20267:10 amRNSDirectorate change
19th Feb 20267:00 amRNSPreliminary Results
11th Feb 20265:30 pmRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNSCentrica announces divestments
2nd Feb 20263:00 pmRNSTotal Voting Rights
26th Jan 20264:15 pmRNSDirector/PDMR Shareholding
13th Jan 20263:00 pmRNSDirector/PDMR Shareholding
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20263:09 pmRNSTransaction in Own Shares - Replacement
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 202612:30 pmRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20254:30 pmRNSCancellation of treasury shares
29th Dec 20254:30 pmRNSCancellation of treasury shares
29th Dec 20251:15 pmRNSDirector/PDMR Shareholding
29th Dec 20251:15 pmRNSDirector/PDMR Shareholding
29th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.